Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL717P (RNA, 7SL, cytoplasmic 717, pseudogene) is a non-coding RNA pseudogene in the human genome. It is derived from the functional 7SL RNA gene, which is part of the signal recognition particle (SRP) complex that regulates protein targeting to membranes. Unlike functional 7SL RNA genes, RN7SL717P does not encode an active RNA or protein and is characterized by sequence similarity with functional SRP genes but lacks the ability to produce a functional product due to mutations, truncations, or the absence of necessary regulatory elements[1][2][5][6]. Pseudogenes such as RN7SL717P arise via direct duplication, retrotransposition, or other genomic processes but generally have no active biological function and are not considered meaningful molecular targets in therapy or diagnostics. If you need information on the functional 7SL RNA (not the pseudogene), it is involved in the SRP complex for directing nascent proteins to the endoplasmic reticulum and has established biological roles and disease relevance[3][4]. However, RN7SL717P itself does not share these characteristics.
None applicable; no known drug targets this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 717, pseudogene (RN7SL717P).